- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- July 2025
- 383 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1773EUR$2,000USD£1,541GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1773EUR$2,000USD£1,541GBP
- Report
- June 2025
- 400 Pages
Global
From €4387EUR$4,949USD£3,814GBP
- Report
- May 2025
- 204 Pages
Global
From €4427EUR$4,995USD£3,849GBP
- Report
- May 2025
- 191 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- April 2025
- 150 Pages
Global
From €2881EUR$3,250USD£2,504GBP
€4299EUR$4,850USD£3,737GBP
- Report
- June 2025
- 400 Pages
Global
From €4387EUR$4,949USD£3,814GBP
- Report
- November 2024
- 192 Pages
Global
From €2216EUR$2,500USD£1,926GBP
- Report
- June 2025
- 200 Pages
Global
From €2472EUR$2,789USD£2,149GBP
- Report
- June 2025
- 200 Pages
Global
From €2472EUR$2,789USD£2,149GBP
- Clinical Trials
- February 2025
- 104 Pages
Global
From €3058EUR$3,450USD£2,659GBP
- Report
- May 2025
- 107 Pages
United States
- Report
- December 2022
- 100 Pages
Global
From €5274EUR$5,950USD£4,585GBP
- Report
- May 2024
- 132 Pages
Global
From €5761EUR$6,499USD£5,008GBP
- Report
- January 2022
- 60 Pages
Global
From €3501EUR$3,950USD£3,044GBP
- Report
- June 2024
- 180 Pages
Global
From €3390EUR$3,825USD£2,948GBP
€3989EUR$4,500USD£3,468GBP
- Report
- June 2024
- 200 Pages
Global
From €7047EUR$7,950USD£6,126GBP
- Report
- June 2024
- 160 Pages
Global
From €2216EUR$2,500USD£1,926GBP

The Autism Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Autism drugs are used to treat the core symptoms of autism spectrum disorder, such as impaired social interaction, communication difficulties, and repetitive behaviors. These drugs are typically prescribed in combination with behavioral therapies, and may include antipsychotics, antidepressants, and stimulants.
The Autism Drug market is highly competitive, with a range of pharmaceutical companies offering treatments. Some of the major players in the market include Eli Lilly, Johnson & Johnson, Pfizer, Novartis, and AbbVie. Other companies, such as Otsuka Pharmaceuticals, Sunovion Pharmaceuticals, and Merck, also offer treatments for autism spectrum disorder. Show Less Read more